MM-064 Updated Progression-Free Survival and Depth of Response in IKEMA, a Randomized Phase 3 Trial of Isatuximab, Carfilzomib, and Dexamethasone (Isa-Kd) Versus Kd in Relapsed Multiple Myeloma — Thomas G. Martin (2022) | RDL Network
MM-064 Updated Progression-Free Survival and Depth of Response in IKEMA, a Randomized Phase 3 Trial of Isatuximab, Carfilzomib, and Dexamethasone (Isa-Kd) Versus Kd in Relapsed Multiple Myeloma
Özgür Pektaş, Philippe Moreau, Meletios A Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, France Casca, Sandrine Macé, Marie‐Laure Risse, Thomas G. Martin
Kwee Yong, Philippe Moreau, Meletios A Dimopoulos, Joseph Mıkhael, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, France Casca, Sandrine Macé, Marie‐Laure Risse, T. John Martin
Thomas G. Martin, Roman Hájek, Philippe Moreau, Bradley Augustson, Nelson Méndez, Tomáš Pika, Sosana Delimpasi, Javier de la Rubia, Ângelo Maiolino, Tony Reiman, Joaquín Martínez‐López, Joseph Mıkhael, Kwee Yong, Marie‐Laure Risse, France Casca, Sylvia Marion, Sandrine Macé, Meletios A Dimopoulos
Thomas G. Martin, Roman Hájek, Philippe Moreau, Bradley Augustson, Nelson Méndez, Tomáš Pika, Sosana Delimpasi, Javier de la Rubia, Ângelo Maiolino, Tony Reiman, Joaquín Martínez‐López, Joseph Mıkhael, Kwee Yong, Marie‐Laure Risse, France Casca, Sylvia Marion, Sandrine Macé, Meletios A Dimopoulos
Kwee Yong, T. John Martin, Meletios A Dimopoulos, Joseph Mıkhael, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, Ross Baker, Kihyun Kım, Gracia Martínez, Chang‐Ki Min, Luděk Pour, Xavier Leleu, Albert Oriol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie‐Laure Risse, Philippe Moreau
Discussion(0)
No comments yet. Be the first to comment.